Rezolute Inc (RZLT)
2.60
-0.29
(-10.03%)
USD |
NASDAQ |
Apr 25, 16:00
2.60
0.00 (0.00%)
After-Hours: 20:00
Rezolute Cash from Financing (TTM): -0.293M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -0.293M |
September 30, 2023 | 0.00 |
June 30, 2023 | 11.57M |
March 31, 2023 | 105.68M |
December 31, 2022 | 105.66M |
September 30, 2022 | 157.96M |
June 30, 2022 | 148.98M |
March 31, 2022 | 69.16M |
December 31, 2021 | 68.97M |
September 30, 2021 | 54.12M |
June 30, 2021 | 51.53M |
March 31, 2021 | 37.24M |
December 31, 2020 | 37.46M |
September 30, 2020 | -0.021M |
June 30, 2020 | 22.55M |
March 31, 2020 | 22.55M |
December 31, 2019 | 46.05M |
September 30, 2019 | 47.57M |
June 30, 2019 | 25.00M |
March 31, 2019 | 28.90M |
December 31, 2018 | 6.60M |
September 30, 2018 | 5.10M |
June 30, 2018 | 9.54M |
March 31, 2018 | 9.416M |
Date | Value |
---|---|
December 31, 2017 | 12.72M |
September 30, 2017 | 16.04M |
June 30, 2017 | 13.93M |
March 31, 2017 | 15.94M |
December 31, 2016 | 14.53M |
September 30, 2016 | 13.08M |
June 30, 2016 | 10.73M |
March 31, 2016 | 6.191M |
December 31, 2015 | 5.700M |
September 30, 2015 | 10.01M |
June 30, 2015 | 10.04M |
March 31, 2015 | 12.00M |
December 31, 2014 | 14.60M |
September 30, 2014 | 9.932M |
June 30, 2014 | 9.932M |
March 31, 2014 | 6.563M |
December 31, 2013 | 1.625M |
September 30, 2013 | 0.7425M |
June 30, 2013 | 1.418M |
March 31, 2013 | 0.421M |
December 31, 2012 | 1.316M |
September 30, 2012 | 0.6855M |
June 30, 2012 | 0.0105M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-0.293M
Minimum
Dec 2023
157.96M
Maximum
Sep 2022
53.25M
Average
46.05M
Median
Dec 2019
Cash from Financing (TTM) Benchmarks
NovaBay Pharmaceuticals Inc | 1.91M |
Palatin Technologies Inc | 5.553M |
iBio Inc | 10.68M |
Theriva Biologics Inc | 0.625M |
Oragenics Inc | 0.2839M |